Conecte-se

Bibliografias temáticas / HIV (Viruses) Gene therapy / Livros

Livros sobre o tema "HIV (Viruses) Gene therapy"

Siga este link para ver outros tipos de publicações sobre o tema: HIV (Viruses) Gene therapy.

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 1 de fevereiro de 2022

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores livros para estudos sobre o assunto "HIV (Viruses) Gene therapy".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os livros das mais diversas áreas científicas e compile uma bibliografia correta.

1

Bauer, Gerhard, e Joseph S. Anderson. Gene Therapy for HIV. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0434-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Vos, Jean-Michel H., ed. Viruses in Human Gene Therapy. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0555-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Singwi, Sanjeev. HIV gene therapy using nucleases. Ottawa: National Library of Canada, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Smith, Clay. Gene Therapy for HIV Infection. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-662-11821-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Hengge, Ulrich R. Immunotreatment and gene therapy of HIV infection. Bremen: Uni-Med, 2004.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Berkhout, Ben, Hildegund C. J. Ertl e Marc S. Weinberg, eds. Gene Therapy for HIV and Chronic Infections. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2432-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Virology, Conference on. HIV and other highly pathogenic viruses. San Diego: Academic Press, 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Canada, Canada Health and Welfare. Therapy and management of CMV in patients with HIV infection/ by Susan M.King. Ottawa: Health and Welfare Canada, 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Lombardi, Rocco Anthony. GAG and ENV trans-dominant mutants for use in ANTI-HIV-1 gene therapy. Ottawa: National Library of Canada, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Catalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Catalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Mindel, Adrian. AIDS: A pocket book of diagnosis and management. 2^a ed. London: Arnold, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Brambilla, Riccardo. Viral vector approaches in neurobiology and brain diseases. New York: Humana Press, 2013.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

International Washington Spring Symposium (10th 1990 George Washington University). Advances in molecular biology and targeted treatment for AIDS. New York: Plenum Press, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Tokyo Institute of Psychiatry. International Symposium. Cutting edge medicine and liaison psychiatry: Psychiatric problems of organ transplantation, cancer, HIV/AIDS, and genetic therapy : proceedings of the 13th Tokyo Institute of Psychiatry International Symposium held in Tokyo on 29-30 September 1998. Editado por Matsushita Masaaki 1937- e Fukunishi Isao. Amsterdam: Elsevier, 1999.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Juelg, Boris, e Rajesh Gandhi. HIV Cure Strategies. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0006.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

Although current antiretroviral therapy (ART) is highly effective at controlling HIV-1 replication, it does not eradicate or cure the infection. HIV-1 persists quiescently in cellular reservoirs, not detected by the immune system due to the lack of active viral replication; these reservoirs represent the major obstacle for cure approaches. Reversal of HIV-1 latency and induction of virus expression by a variety of interventions may render infected cells susceptible to immune recognition and active clearance. Strategies to boost immune responses via vaccination, immunomodulation, or gene therapy are being evaluated with the aim of achieving HIV-1 control without antiretroviral therapy, if not viral eradication.

17

H, Vos Jean-Michel, ed. Viruses in human gene therapy. Durham, N.C: Carolina Academic Press, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Naicker, Saraladevi, e Graham Paget. HIV and renal disease. Editado por Vivekanand Jha. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0187_update_001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

The human immunodeficiency virus (HIV) infection epidemic has particularly affected the poorest regions of the world. HIV can directly or indirectly affect different aspects of renal function, and results in a variable expression of kidney disease.Acute kidney injury (AKI) occurs in approximately 20% of hospitalized patients. The prevalence of chronic kidney disease (CKD) amongst HIV-infected patients is reported at 3.5–38% in different regions of the world. The complex interplay between the pheno- and/or genotypic variants of the virus, the genetic make-up of the host, and environmental factors determine the clinical manifestations of renal disease. The association of APOL1 gene variants G1 and G2 with the risk of focal segmental glomerulosclerosis explains the high frequency of HIV-associated nephropathy (HIVAN) in populations of black ethnicity.Anti-retroviral therapy (ART) is effective in preventing progression of HIVAN. Some of the drugs used in ART regimens are potentially nephrotoxic and require dose adjustment or even avoidance in CKD. Progression to end-stage renal disease (ESRD) in HIVAN has been reported to correlate with the extent of chronic damage quantified by renal biopsy.HIV-infected patients requiring dialysis, who are stable on ART, are achieving survival rates comparable to those of non-HIV dialysis populations. Similarly, HIV infection does not seem to adversely affect patient and graft survival rates after kidney transplantation, and there has been no increase in the prevalence of opportunistic infections in transplant recipients on effective ART.

19

Gene therapy for HIV infection. Georgetown, Tex: R.G. Landes, 1998.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Ian, Phillips M., ed. Gene therapy methods. San Diego, Calif: Academic Press, 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Berkhout, Ben, Hildegund C. J. Ertl e Marc S. Weinberg. Gene Therapy for HIV and Chronic Infections. Springer, 2015.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Sax, Paul E., Calvin J. Cohen e Daniel R. Kuritzkes. HIV Essentials 2010. Jones & Bartlett Learning, 2009.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Cid-Arregui, Angel. Viral Vectors: Basic Science and Gene Therapy. EATON PUBLISHING, 2000.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Biloshytsky, Vadym, e Roman Cregg. Pioneering use of gene therapy for pain. Editado por Paul Farquhar-Smith, Pierre Beaulieu e Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0083.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

The landmark paper discussed in this chapter is ‘Gene therapy for pain: Results of a Phase I clinical trial’, published by Fink et al. in 2011. In this study, the first of its kind, researchers studied the efficacy and safety of a modified herpes simplex virus (HSV) vector used to deliver PENK, which encodes proenkephalin, which is cleaved into the enkephalin peptides Met-enkephalin and Leu-enkephalin, which induce analgesia by acting on opioid receptors. The development of the HSV vector was based in part on results studies in which adenovirus, adeno-associated virus, or non-viral vectors were used to overexpress genes. Overexpression of a variety of large molecules leads to a reduction in pain-related behaviour in animals. Gene therapy in the treatment of chronic pain seems to offer a promising alternative to systemic or highly invasive therapies. However, additional research is needed to determine the safety, effectiveness, and cost-efficiency of this approach.

25

(Editor), Jacqueline D. Reeves, e Cynthia A. Derdeyn (Editor), eds. Entry Inhibitors in HIV Therapy (Milestones in Drug Therapy) (Milestones in Drug Therapy). BirkhÃ¤user Basel, 2007.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

A, Haseltine William, Wong-Staal Flossie e Harvard AIDS Institute, eds. Genetic structure and regulation of HIV. New York: Raven Press, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Bauer, Gerhard, e Joseph S. Anderson. Gene Therapy for HIV: From Inception to a Possible Cure. Springer, 2014.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Robert, Franza B., Cullen Bryan e Wong-Staal Flossie, eds. The Control of human retrovirus gene expression. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

1958-, Harrington Kevin J., Pandha Hardev e Vile Richard G, eds. Viral therapy of cancer. Chichester, West Sussex, England: John Wiley & Sons, 2007.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Harrington, K. J. Viral Therapy of Cancer. John Wiley & Sons, 2008.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

(Editor), P. R. Lowenstein, e L. W. Enquist (Editor), eds. Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders. John Wiley & Sons, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

R, Lowenstein P., e Enquist L. W, eds. Protocols for gene transfer in neuroscience: Towards gene therapy of neurological disorders. Chichester: J. Wiley & Sons, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Factor, Phillip H. Gene Therapy for Acute and Acquired Diseases. Springer, 2012.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Factor, Phillip H. Gene Therapy for Acute and Acquired Diseases. Springer, 2001.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Emini, Emilio. The Human Immunodeficiency Virus: Biology, Immunology, and Therapy. Princeton University Press, 2001.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

The Human immunodeficiency virus: Biology, immunology, and therapy. Princeton, N.J: Princeton University Press, 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

A, Machida Curtis, ed. Viral vectors for gene therapy: Methods and protocols. Totowa, N.J: Humana Press, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

A, Machida Curtis, ed. Viral vectors for gene therapy: Methods and protocols. Totowa, N.J: Humana Press, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

A, Machida Curtis, ed. Viral vectors for gene therapy: Methods and protocols. Totowa, New Jersey: Humana Press, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Medina, Maria Fe C. Strategies for isolation and expression of ribozymes for use in HIV gene therapy. 2000.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

(Editor), Michael G. Kaplitt, e Arthur D. Loewy (Editor), eds. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

G, Kaplitt Michael, e Loewy Arthur D, eds. Viral vectors: Gene therapy and neuroscience applications. San Diego: Academic Press, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

(Editor), Michael G. Kaplitt, e Arthur D. Loewy (Editor), eds. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

(Editor), Michael G. Kaplitt, e Arthur D. Loewy (Editor), eds. Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

(Editor), Boro Dropulic, e Barrie Carter (Editor), eds. Concepts in Genetic Medicine. Wiley, 2008.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Concepts in genetic medicine. Hoboken, N.J: John Wiley & Sons, 2007.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Machida, Curtis A. Viral Vectors for Gene Therapy: Methods and Protocols (Methods in Molecular Medicine). Humana Press, 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Ramezani, Ali. Development and testing of mono- and multimeric hammerhead ribozymes for HIV-1 gene therapy. 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

G, Giraldo, ed. Development and applications of vaccines and gene therapy in AIDS. Basel: Karger, 1996.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.